Navigation Links
Fibroblasts contribute to melanoma tumor growth, say Moffitt Cancer Center researchers
Date:1/5/2012

TAMPA, Fla. -- Fibroblasts, cells that play a role in the structural framework of tissues, play an apparent role in melanoma tumor growth. Fibroblasts also contribute to melanoma drug resistance and may also facilitate the "flare" response when a tumor's metabolism is enhanced following a patient being removed from a targeted therapy, said researchers at Moffitt Cancer Center in Tampa, Fla.

Alexander R. Anderson, Ph.D., co-director of Integrative Mathematical Oncology at Moffitt, and Moffitt Comprehensive Melanoma Research Center member Keiran S. Smalley, Ph.D., along with colleagues from the Wistar Institute in Philadelphia, investigated the role of fibroblasts in melanoma progression and published their findings in a recent issue of Molecular Pharmaceutics.

"A role for fibroblasts in cancer progression has long been suspected," explained Anderson, who works with mathematical models of cancer to investigate tumor cell- microenvironment interactions. "In this study, we used an integrated mathematical and experimental approach to investigate whether melanoma cells recruit, activate and stimulate fibroblasts to deposit certain proteins known to be pro-survival for melanoma cells."

Fibroblasts are the most common of connective tissues, and they function to synthesize the "extra cellular matrix" of cells and collagen, the structural framework also called "stroma" for tissues.

The researchers knew that fibroblasts were drawn to cancer cells and that they became activated by cancer cells. They also knew that different cancer cell lines have varying capabilities for recruiting and stimulating fibroblasts. An expectation has been that aggressive cancers stimulate fibroblasts more than do less aggressive cancers.

When they investigated the relationship between fibroblasts and tumors using mathematical models, the research team came up with some unexpected findings.

Anderson and Smalley expected the fibroblast-derived "extra cellular matrix" that supports the tumor structure to have "direct effects on tumor behavior." However, once they ran their theoretical models they came up with a number of unexpected conclusions with potentially far-reaching implications about drug resistance and tumor growth.

"Our finding that the fibroblast population might facilitate the "flare response" a period during which a tumor has enhanced metabolism and increases it progression trajectory after patients are removed from targeted therapy was a surprise," said Smalley, whose research aims at developing new therapies for melanoma and getting them into clinical practice.

The researchers knew that a targeted therapy would kill only the tumor population, not the fibroblasts in the tumor structure. However, the finding that fibroblasts contribute to melanoma drug resistance was unexpected.

"Targeted therapies may actually hasten tumor progression when they are stopped due to resistance to the targeted drug," said Smalley. "We found in our models that fibroblasts appear to facilitate the flare response after targeted therapy ends."

Their conclusions about the relationship between fibroblasts and cancer tumors were not predicted or expected, but revealed though the use of mathematical models.

"If these conclusions are confirmed experimentally, we may gain important new insights into how drug resistance can be managed clinically," concluded Anderson.


'/>"/>
Contact: Ferdie De Vega
Ferdinand.DeVega@moffitt.org
813-745-7858
H. Lee Moffitt Cancer Center & Research Institute
Source:Eurekalert

Related medicine news :

1. Football could contribute to strokes in adolescents
2. Sewage treatment plants may contribute to antibiotic resistance problem
3. Low vitamin D levels may contribute to development of Type 2 diabetes
4. Past Trauma May Contribute to Bowel Disorder
5. Common medications can contribute to lower urinary tract symptoms in men
6. Poor gut sense of numbers contributes to persistent math difficulties
7. Sleep loss in early childhood may contribute to the development of ADHD symptoms
8. Cell division abnormality contributes to inflammation in COPD
9. Disruption of nerve cell supply chain may contribute to Parkinsons
10. Severity of hepatitis C and HIV co-infection in mothers contribute to HCV transmission to child
11. MRI may contribute to early detection of Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , Belgium , June ... MKT: VNRX), today announced the appointment of Dr. ... of Directors as a Non-Executive Director, effective June ... Company,s Audit, Compensation and Nominations and Governance Committees.  ... Dr. Futcher will provide independent expertise and strategic ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
Breaking Medicine Technology: